M. Wheater

发表

Clinical outcomes following neoadjuvant cisplatin-based chemotherapy for bladder cancer in elderly compared with younger patients.

S. Crabb, C. Chau, T. Geldart, 2015, European journal of cancer care.

Serum total hCGβ level is an independent prognostic factor in transitional cell carcinoma of the urothelial tract

S. Crabb, J. Douglas, G. Mead, 2014, British Journal of Cancer.

Outcome of Men With Relapses After Adjuvant Bleomycin, Etoposide, and Cisplatin for Clinical Stage I Nonseminoma.

C. Bokemeyer, J. Shamash, C. Fankhauser, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Outcome and biomarker analysis from a multi-centre phase 2 study of ipilimumab in combination with carboplatin and etoposide (ICE) as first line therapy for extensive stage small cell lung cancer

S. Danson, E. Arriola, L. Nolan, 2016 .

Phase II trial Paclitaxel with or without trametinib or pazopanib in advanced wild-type BRAF Melanoma (PACMEL): a multicentre, open-label, randomised, controlled phase II trial

D. Schadendorf, S. Love, C. Mauch, 2018 .

Infliximab for IPILIMUMAB-Related Colitis—Letter

G. Thomas, I. Karydis, C. Ottensmeier, 2015, Clinical Cancer Research.

Ipilimumab in the real world: the UK expanded access programme experience in previously treated advanced melanoma patients

J. Larkin, R. Plummer, A. Dalgleish, 2015, Melanoma research.

Immunosuppression for ipilimumab-related toxicity can cause pneumocystis pneumonia but spare antitumor immune control

R. Krishnan, C. Ottensmeier, E. Arriola, 2015, Oncoimmunology.

Outcome of Men With Relapse After Adjuvant Carboplatin for Clinical Stage I Seminoma.

J. Shamash, P. Hutton, O. Ståhl, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Treatment outcome and patterns of relapse following adjuvant carboplatin for stage I testicular seminomatous germ-cell tumour: results from a 17-year UK experience.

S. Crabb, R. Cathomas, M. Fehr, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

The 111 Study: A Single-arm, Phase 3 Trial Evaluating One Cycle of Bleomycin, Etoposide, and Cisplatin as Adjuvant Chemotherapy in High-risk, Stage 1 Nonseminomatous or Combined Germ Cell Tumours of the Testis☆

R. Huddart, J. Shamash, P. Hutton, 2019, European urology.

Systemic immune-inflammation index predicts the clinical outcome in patients with metastatic renal cell cancer treated with sunitinib

E. Scarpi, V. Conteduca, R. Berardi, 2016, Oncotarget.

Chemosaturation with percutaneous hepatic perfusion of melphalan for metastatic uveal melanoma

B. Stedman, I. Karydis, G. Vigneswaran, 2022, Melanoma research.

Successful use of adalimumab in immune checkpoint inhibitor-associated inflammatory arthritis

I. Karydis, D. Wallis, M. Wheater, 2018, Rheumatology advances in practice.

Evaluation of immune infiltration in the colonic mucosa of patients with ipilimumab-related colitis

G. Thomas, C. Ottensmeier, E. Arriola, 2016, Oncoimmunology.

A rare case of testicular mixed germ cell tumour with adrenal metastasis

R. Lockyer, M. Wheater, A. King, 2021 .

Liver resection for metastatic uveal melanoma: experience from a supra-regional centre and review of literature

B. Stedman, I. Karydis, A. Takhar, 2022, Melanoma research.

Late relapse (>2 years) on surveillance in stage I non‐seminomatous germ cell tumours; predominant seminoma only histology

P. Simmonds, L. Nolan, J. Kirby, 2010, BJU international.

A Randomised Phase 2 Study of AZD2014 Versus Everolimus in Patients with VEGF-Refractory Metastatic Clear Cell Renal Cancer.

S. Sundar, A. Robinson, T. Powles, 2016, European urology.

Outcome and Biomarker Analysis from a Multicenter Phase 2 Study of Ipilimumab in Combination with Carboplatin and Etoposide as First-Line Therapy for Extensive-Stage SCLC

J. Cave, I. Galea, C. Ottensmeier, 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Paclitaxel with or without trametinib or pazopanib in advanced wild-type BRAF melanoma (PACMEL): a multicentre, open-label, randomised, controlled phase II trial

D. Schadendorf, C. Mauch, S. Love, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Relevant risk of carboplatin underdosing in cancer patients with normal renal function using estimated GFR: lessons from a stage I seminoma cohort.

R. Cathomas, G. Mead, M. Fehr, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Percutaneous hepatic perfusion with melphalan in uveal melanoma: A safe and effective treatment modality in an orphan disease

B. Stedman, Sanjay Gupta, A. Gangi, 2017, Journal of surgical oncology.

Clinical activity and safety of Pembrolizumab in Ipilimumab pre-treated patients with uveal melanoma

P. Szlosarek, I. Karydis, C. Ottensmeier, 2016, Oncoimmunology.

Multidisciplinary Treatment of Cancer: Chemotherapy

S. Lowndes, Peter W M Johnson, M. Wheater, 2009 .

The clinical features and management of testicular germ cell tumours in patients aged 60 years and older

G. Mead, P. Simmonds, L. Nolan, 2011, BJU international.

Percutaneous hepatic perfusion (PHP) with melphalan for patients with ocular melanoma liver metastases: Preliminary results of FOCUS (PHP-OCM-301/301A) phase III trial.

A. Gesierich, A. Ejaz, R. Dummer, 2021 .

Genitourinary tumors, non-prostate

S. J. Park, I. Tannock, S. Groshen, 2012 .

1477PA NOVEL PHASE II TRIAL OF IPILIMUMAB, CARBOPLATIN AND ETOPOSIDE (ICE) FOR THE FIRST LINE TREATMENT OF EXTENSIVE STAGE SMALL CELL LUNG CANCER (SCLC).

J. Cave, I. Galea, C. Ottensmeier, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Temporary treatment cessation versus continuation of first-line tyrosine kinase inhibitor in patients with advanced clear cell renal cell carcinoma (STAR): an open-label, non-inferiority, randomised, controlled, phase 2/3 trial.

V. Goh, T. Powles, M. Highley, 2023, The Lancet. Oncology.

Salvage Chemotherapy With Gemcitabine, Paclitaxel, Ifosfamide, and Cisplatin for Relapsed Germ Cell Cancer

R. Huddart, G. Rustin, G. Mead, 2018, Clinical genitourinary cancer.

The role of MNK proteins and eIF4E phosphorylation in breast cancer cell proliferation and survival

J. Blaydes, Peter W M Johnson, M. Wheater, 2010, Cancer biology & therapy.

P. Simmonds, M. Wheater, 2011 .

Biomarker for benefit from ipilimumab: Correlation of breadth of humoral tumor-antigen-specific immunity with outcome.

C. Ottensmeier, H. Hepburne-Scott, J. Theaker, 2012 .

1099PA RETROSPECTIVE ANALYSIS OF SAFETY AND OUTCOME OF RADIOTHERAPY GIVEN FOLLOWING TREATMENT WITH IPILIMUMAB FOR METASTATIC MELANOMA.

E. Killick, A. King, G. Sharpe, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.